au.\*:("MARASCO, W. A")
Results 1 to 20 of 20
Selection :
Intracellular antibodies : development and therapeutic potentialRICHARDSON, J. H; MARASCO, W. A.Trends in biotechnology (Regular ed.). 1995, Vol 13, Num 8, pp 306-310, issn 0167-7799Article
Intracellular antibodies (intrabodies) for gene therapy of infectious diseasesRONDON, I. J; MARASCO, W. A.Annual review of microbiology. 1997, Vol 51, pp 257-283, issn 0066-4227Article
Localization of chemotactic peptide receptors on rabbit neutrophilsWALTER, R. J; MARASCO, W. A.Experimental cell research. 1984, Vol 154, Num 2, pp 613-618, issn 0014-4827Article
Unusual presentation of cat scratch disease in a patient positive for antibody to the human immunodeficiency virusMARASCO, W. A; LESTER, S; PARSONNET, J et al.Reviews of infectious diseases. 1989, Vol 11, Num 5, pp 793-803, issn 0162-0886Article
Intracellular Antibodies (Intrabodies) and Their Therapeutic PotentialLO, A. S.-Y; ZHU, Q; MARASCO, W. A et al.Handbook of experimental pharmacology. 2008, Vol 181, pp 343-373, issn 0171-2004, 31 p.Article
Antibodies for targeted gene therapy : extracellular gene targeting and intracellular expressionJONES, S. D; MARASCO, W. A.Advanced drug delivery reviews. 1998, Vol 31, Num 1-2, pp 153-170, issn 0169-409XArticle
Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion productionFANTONE, J. C; MARASCO, W. A; ELGAS, L. J et al.The American journal of pathology. 1984, Vol 115, Num 1, pp 9-16, issn 0002-9440Article
Novel genetic immunotoxins and intracellular antibodies for cancer therapySI-YI CHEN; MARASCO, W. A.Seminars in oncology. 1996, Vol 23, Num 1, pp 148-153, issn 0093-7754Article
Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibodyMARASCO, W. A; BAGLEY, J; ZANI, C et al.The Journal of clinical investigation. 1992, Vol 90, Num 4, pp 1467-1478, issn 0021-9738Article
Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptorMARASCO, W. A; BECKER, K. M; FELTNER, D. E et al.Biochemistry (Easton). 1985, Vol 24, Num 9, pp 2227-2236, issn 0006-2960Article
Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coliMARASCO, W. A; PHAN, S. H; KRUTZSCH, H et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 9, pp 5430-5439, issn 0021-9258Article
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120MASIERO, S; DEL VECCHIO, C; PAROLIN, C et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 4, pp 299-310, issn 0969-7128, 12 p.Article
Ibuprofen-associated renal dysfunction: pathophysiologic mechanisms of acute renal failure, hyperkalemia, tubular necrosis, and proteinuriaMARASCO, W. A; GIKAS, P. W; AZZIZ-BAUMGARTNER, R et al.Archives of internal medicine (1960). 1987, Vol 147, Num 12, pp 2107-2116, issn 0003-9926Article
Inhibition of neutrophil activation by p-bromophenacyl bromide and its effects on phospholipase A2DUQUE, R. E; FANTONE, J. C; KRAMER, C et al.British journal of pharmacology. 1986, Vol 88, Num 2, pp 463-472, issn 0007-1188Article
Chemotactic factor binding by metastatic tumour cells: evidence for a formyl-peptide receptor on a non-myelogenous cellMARASCO, W. A; WARD, P. A; FELTNER, D. E et al.Journal of Cell Science. 1985, Vol 73, pp 121-134, issn 0021-9533Article
Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodiesMHASHILKAR, A. M; LAVECCHIO, J; RAMSTEDT, U et al.Human gene therapy. 1999, Vol 10, Num 9, pp 1453-1467, issn 1043-0342Article
Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7QUAN ZHU; CONGMEI ZENG; DAUMY, G et al.Journal of immunological methods. 1999, Vol 231, Num 1-2, pp 207-222, issn 0022-1759Article
Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV- 1-infection and AIDSMARASCO, W. A; LAVECCHIO, J; WINKLER, A et al.Journal of immunological methods. 1999, Vol 231, Num 1-2, pp 223-238, issn 0022-1759Article
Recombinant human tumor necrosis factor-α: regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophilsATKINSON, Y. H; MARASCO, W. A; LOPEZ, A. F et al.The Journal of clinical investigation. 1988, Vol 81, Num 3, pp 759-765, issn 0021-9738, 7 p.Article
